Definitive Contract 75A50122C00055
Award Date
10/1/22
Potential Completion Date
2/15/24
Potential Value
$7.8B
Awardee
Moderna US, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Joint Program Executive Office for Chemical and Biological Defense, a Defense Department agency, to Moderna, Inc. for 100 million doses of the SARS-CoV-2 mRNA-1273 vaccine. The $8.2 billion firm fixed price contract has an ultimate completion date of August 10, 2023. Moderna, a manufacturer of pharmaceutical goods, has previously received prime and subcontract awards from various government agencies including the Department of Veterans Affairs,...
<p>The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded a Definitive Contract valued at $7,837,399,999.00 to Moderna US, Inc. Moderna US Inc. Division for COVID-19 MRNA Vaccines. The place of performance will be in Cambridge, MA 02139, USA and the period of performance is from July 28, 2022 through March 31, 2023. The pricing structure is Firm Fixed Price.</p>
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,557.98 firm fixed price delivery order is for the procurement of 50 million doses of the Moderna COVID-19 vaccine. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $2,605.08 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MODERNA COVID 24-25(6M-11Y)EUA 0.25ML vaccines. The award has an ultimate completion date of July 8, 2025 and is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and this delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held with DLA Troop Support Medical to...
This federal contract award, valued at $1,908.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA), with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $15,189.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of November 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This is a $3,037.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA) in 0.25 mL doses. The contract is not designated as a set-aside and represents a single delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency awarded a $4,662.84 firm fixed price delivery order to Amerisourcebergen Drug Corp for 50 million doses of the Moderna COVID-19 mRNA vaccine. Performance will take place in Conshohocken, Pennsylvania over a period of approximately one month, from September 25th to October 17th, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor in fulfilling this order to supply additional COVID-19...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Modernatx, Inc. The $81,397,873.67 cost-plus-fixed-fee contract is to advance the development of a messenger RNA (mRNA) vaccine for the prevention of Zika virus. The contract has a completion date of July 1, 2024. Modernatx, Inc. is a for-profit manufacturer of pharmaceutical goods that has provided...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,605.08 firm fixed-price delivery order is for the supply of Moderna COVID-19 vaccines for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The award has an ultimate completion date of December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with...